手性5-(R)-(1′R,2′S,5′R)-孟氧基丁内酯并[3,4-b]-2(S)-6(R)-1-N-环己基氮杂环丙烷的合成及晶体结构

环己胺与手性元5-(R)-(1′R,2′S,5′R)-孟氧基-3-溴-2(5H)-呋喃酮的不对称M ichael加成/分子内亲核取代反应,得到含有两个新手性中心的氮杂环丙烷/稠合丁内酯标题化合物。对其进行了谱学表征和X-射线单晶衍射测定。标题化合物分子式为C20H33NO3,M r=335.47,三斜晶系,P1空间群,晶胞参数:a=5.438(11)。A,b=8.117(2)。A,c=11.572(2)。A,α=96.84(3)°,β=94.48(3)°,γ=101.86(3),°V=493.5(2)。A3,Z=1,D c=1.129g/cm3,R=0.0867,wR=0.2344。     

螺[1-溴-4-(1R,2S,5R)-l-孟氧基-5-氧杂-6-氧代双环[3.1.0]己烷-2,2'-(3'-α-膦酸二乙酯基-(S)-苯甲氧基-4'-l-(1R,2S,5R)-孟氧基丁内酯)]的晶体结构

报道了标题化合物合成和晶体结构。X-射线结构分析表明,该化合物的分子式为C39H58BrO10P,Mr = 797.74,晶体属于单斜晶系,空间群为P21,晶胞参数a = 12.858(3), b = 25.130(5), c = 14.125(3) ? = 105.15(3), V = 4405(2) ?, Z = 4, Dc = 1.203 g/cm3, ?= 1.019 mm-1, F(000) = 1688,R = 0.0726, wR = 0.1201,共收集到9691个独立衍射点,其中可观测点5638个(I≥2s(I))。每个分子中有6个环,13个手性中心,2个五员环呈信封式构象,并分别与三员环组合成[2.4]螺环和[3.1.0]桥环化合物,4个新生成的手性中心的绝对构型为C(6)(S), C(7)(S), C(3)(R), C(2)(R),新引入的磷酸酯官能团C(9)为S构型。     

R-(—)-1-氯甲基-4-乙基-2,8,9-三氧杂-5-氮杂-1-硅杂三环[3,3,3,0~(1.5)]十一碳烷的晶体结构

杂氮硅三环是一类具有特殊生理活性的新型有机硅化合物,有关其合成及性质在近20年中已有大量报道。特别是当R为氯甲基时,该化合物的生理活性很高,用它制成的药膏已用来治疗脱发及伤口愈合。因此,1-氯甲基杂氮硅三环(Ⅰ)的分子结构引起了人们的关注,先后有人报道了(Ⅰ)及1-氯甲基-3,7-二甲基,1-氯甲基-3,7,10-三甲基     

相转移催化(PTC)合成β-[2′-降冰片-5′-烯]α,β不饱和酮、醛类

某些α,β不饱和酮、醛类化合物具有浓郁的果香,木香味,广泛存在于天然的精油、水果、蔬菜中,也是重要的有机合成中间体。对于它们的合成近来有不少报道。如β-[2′-降冰片-5′-烯]α,β不饱和酮醛类具有特     

4-(4-N,N-二甲胺基)苯基-7,7-二甲基-5-氧代-3,4,5,6,7,8-六氢香豆素酮的合成和晶体结构

标题化合物C19H23NO3由4-N,N-二甲胺基苯甲醛、5,5-二甲基-1,3-环己二酮、麦氏酸在乙二醇中于80℃反应2.5小时而得。结构通过单晶X-射线衍射法确定,其晶体属单斜晶系, C19H23NO3,空间群P21, a = 9.364(2), b = 5.974(1), c = 15.731(3)?, b = 102.87(3)°, V = 857.9(3)?3, Z = 2, Dc = 1.213Mg/m3, μ(MoKa) = 0.082mm-1, F(000)=336。晶体结构用直接法解出,经用全矩阵最小二乘法对原子参数进行修正,最终的偏离因子为R=0.0521, wR=0.1392。在分子结构中,存在3个平面, C(10)~C(15)构成平面1,C(5)-C6)-C(8)-C(9)-O(2)构成平面2,C(1)-C(2)- C(4)-C(5)-C(9)构成平面3,平面1与平面2的最小二乘面的两面角为88.77°,平面1与平面3的最小二乘面的两面角为86.58°,平面2与平面3的最小二乘面的两面角为1.86°.     

5-甲氧基-6'-羟基-2,2'-[乙二氧双(氮次甲基)]二酚及其四核锌(Ⅱ)配合物的合成与晶体结构

合成了一种不对称Salamo型配体5-甲氧基-6'-羟基-2,2'-[乙二氧双(氮次甲基)]二酚(H₃L)及其四核锌(Ⅱ)配合物[Zn₄L₂(CH₃OH)₂(OAc)₂],并通过X-射线单晶衍射分析确定了其晶体结构。其中配体呈现一种“V”构型,两个苯环单元的二面角为 85.71(3)°,可近似认为是垂直的,而在配合物晶体结构中,金属离子有两种配位构型方式：一种为三角双锥构型,一种为四方锥构型。配合物通过分子间的氢键作用形成了一个无限延伸的二维结构。     

5-甲氧基-6′-羟基-2,2′-[乙二氧双(氮次甲基)]二酚及其四核锌(Ⅱ)配合物的合成与晶体结构(英文)

合成了一种不对称Salamo型配体5-甲氧基-6′-羟基-2,2′-[乙二氧双(氮次甲基)]二酚(H3L)及其四核锌髤配合物[Zn4L2(CH3OH)2(OAc)2],并通过X-射线单晶衍射分析确定了其晶体结构。其中配体呈现一种"V"构型,两个苯环单元的二面角为85.71(3)°,可近似认为是垂直的;而在配合物晶体结构中,金属离子有两种配位构型方式:一种为三角双锥构型,另一种为四方锥构型。配合物通过分子间的氢键作用形成了一个无限延伸的二维结构。     

螺{1-溴-4-L-孟氧基-5-氧杂-6-氧代双环[3.1.0]己烷-2,3′-(4′-呋喃甲醇基-5′-孟氧基丁内酯)}的合成及其晶体结构

α-呋喃甲醇与手性试剂5-(L-孟氧基)-3-溴-2(5H)-呋喃酮于室温进行串联的不对称双M ichael加成/分子内亲核取代反应,合成了含有4个新手性中心的螺环/环丙烷标题化合物(1,C33H47B rO8,M r=651.62)。其结构经1H NMR,13C NMR,IR,MS,元素分析和四园单晶X-射线衍射仪表征。1属正交晶系,P2(1)2(1)2(1)空间群,a=10.166(2),b=14.980(3),c=23.202(5),α=90°,β=90°,γ=90°,V=3533.4(12)3,Z=4,Dc=1.225 Mg.m-3,μ=0.074 mm-1,F(000)=1376,偏离因子R=0.0701,wR=0.1149。1的分子中共有6个环,12个手性中心,2个六元环呈椅式构象,3个五元环呈信封式构象,4个新生成的手性中心的构型分别是(S)-C1,(S)-C3,(R)-C3,′(R)-C4′。     

螺{1-溴-4-L-孟氧基-5-氧杂-6-氧代双环[3.1.0]己烷-2,3''''-(4''''-呋喃甲醇基-5''''-孟氧基丁内酯)}的合成及其晶体结构

α-呋喃甲醇与手性试剂5-(L-孟氧基)-3-溴-2(5H)-呋喃酮于室温进行串联的不对称双Michael加成/分子内亲核取代反应,合成了含有4个新手性中心的螺环/环丙烷标题化合物(1, C33H47BrO8, Mr=651.62). 其结构经1H NMR, 13C NMR, IR, MS,元素分析和四园单晶X-射线衍射仪表征.1属正交晶系, P2(1)2(1)2(1)空间群, a=10.166(2) (°A), b=14.980(3) (°A), c=23.202(5) (°A), α=90°, β=90°, γ=90°, V=3533.4(12) (°A)3, Z=4, Dc=1.225 Mg·m-3, μ=0.074 mm-1, F(000)=1376,偏离因子R=0.0701, wR=0.1149. 1的分子中共有6个环,12个手性中心,2个六元环呈椅式构象,3个五元环呈信封式构象,4个新生成的手性中心的构型分别是 (S)-C1, (S)-C3, (R)-C3', (R)-C4'.     

10-氯-5-二乙氧基甲基-1,3-二甲基色烯并[4,3-d]吡唑并[3,4-b]吡啶-6(3H)-酮的合成和晶体结构

利用L-脯氨酸催化的5-氯水杨醛(1)与6-甲基-4-羟基吡喃酮(2)的缩合反应及硫酸铜催化下与1,3-二甲基-5-氨基吡唑(3)的串联反应,合成得到了10-氯-1,3-二甲基-5-(2-氧代丙基)色烯并[4,3-d]吡唑并[3,4-b]吡啶-6(3H)-酮(4)和10-氯-5-二乙氧基甲基-1,3-二甲基色烯并[4,3-d]吡唑并[3,4-b]吡啶-6(3H)-酮(5).化合物5的结构通过单晶X射线衍射法确定:晶体属于三斜晶系,空间群P-1;相对分子质量Mr=803.68;晶胞参数a=1.03160(10)nm,b=1.42900(13)nm,c=1.44268(15)nm;V=1.9448(3)nm~3;Z=2;晶胞密度Dc=1.372g/cm~3;吸收系数μ=0.228mm-1;单胞中电子的数目F(000)=840.晶体结构用直接法解出,经全矩阵最小二乘法对原子参数进行修正,最终的偏离因子为R=0.0681,w R=0.2051.在晶体结构中色烯环与吡啶环及吡唑环近似于共平面.     

Synthesis and Crystal Structure of 8-methyl-5-phenyl-4-thia-6-aza-spiro [2.5] oct-5-en-7-ol

1 INTRODUCTION bacterical and so on[3]. Recently, we have reported a novel way to synthesize cyclopropane-annuated sul- Cyclopropane-containing compounds attract the fer or selenium heterocycles[4]. Herein we report the organic chemists for a long time because many of molecule structure of the title compound syhthesized them have biological activities in natural systems[1], by the tandem Michael-nucleophilic addition of thio- including cyclopropyl-amine, cyclopropylmethanols, benzamide an…     

Synthesis and Crystal Structure of 2-Oxo-3-phenyl-1-oxaspiro[4.5]dec-3-en-4-yl 4-chlorobenzoate

The title compound 2-oxo-3-phenyl-1-oxaspiro[4.5]dec-3-en-4-yl 4-chloro-benzoate 6 (C22H19ClO4, Mr = 382.82) has been synthesized by the condensation reaction of 4-hydroxy-3-phenyl-1-oxaspiro[4.5]dec-3-en-2-one 5 with 4-chlorobenzoyl chloride, and its crystal structure was determined by single-crystal X-ray diffraction. The crystal belongs to the monoclinic system, space group P21/n with a = 10.6749(11), b = 6.0573(7), c = 29.680(2) , β = 94.073(3)o, V = 1914.3(3) 3, Z = 4, Dc = 1.328 g/cm3, F(000) = 800, μ = 0.224 mm–1, S = 1.003, the final R = 0.0605 and wR = 0.1500 for 1828 observed reflections with I > 2σ(I) and 244 variable parameters. The crystal analysis shows that the molecular structure of the title compound has one planar furan ring, one chair conformation cyclohexane ring and two benzene rings. The furan and cyclohexane rings adopt whorl conformations.     

Synthesis and Crystal Structure of Spiro[1-bromo(S)-4-(R)-hydroxy- 5-oxa-6-oxo-bicyclo[3.1.0]hexane-2,2''-(3''-diethyl-(-(S)-4''-Cl-benzyloxyphosphonyl-4''-(1R,2S,5R)-menthyloxybutyrolactone)]

The title compound, spiro[1-bromo(S)-4-(R)-hydroxy-5-oxa-6-oxo-bicyclo[3.1.0]-hxane-2,2'-(3'-diethyl-α-(S)-4'-Cl-benzyloxyphosphonyl-4'-(1R,2S,5R)-menthyloxybutyrolactone)] has been synthesized via the tandem asymmetric reaction and it crystallizes in a monoclinic system, space group P21 with a = 11.067(3), b = 12.484(2), c = 12.356(2)(A), β = 101.95°,C29H39BrC1O10P, Mr = 693.93, V= 1670.2(6) (A)3, Z= 2, Dc= 1.380 g/cm3, λ(MoKα) = 0.071073nm, μ = 1.410 mm-1, F(000) = 720, the final R = 0.0570 and wR = 0.0758 for 6190 observed reflections with I ＞ 2σ(I). The structure is characterized by the special combination of biologic phosphonyl group and one cyclopropane as well as two butyrolactones. The intermolecular hydrogen bond between O(3)-H(3A)…O(10) in the crystal lattice has been observed.     

Synthesis and Structure of 5-Amino-6-(4-fluorophenylamino)-3-methylthio-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4(5H)-one

The title compound (C18H15FN6OS) has been synthesized and its crystal structure was determined by X-ray analysis. The crystal belongs to monoclinic system, space group P21/n with a = 13.983(10), b = 7.337(5), c = 16.702(12) (A), α = 90, β = 98.277(12), γ = 90°, V = 1696(2)(A)3, Z = 4, Dc= 1.498 g/cm3, Mr = 382.42,μ = 0.224 mm-1, F(000) = 792, the final R = 0.0362 and wR = 0.0878 for 2579 observed reflections with I ＞ 2σ(Ⅰ). In the title compound, the atoms of C(1),C(2), C(3), C(4), C(5), N(1), N(2), N(3), N(4), N(5), N(6), O(1) and S(1) form a fully delocalized system with the average deviation of 0.0307(A). There exists a part of electron delocalization over the planes of Ⅰ (pyrazolo[3,4-d]pyrimidin-4-one moiety), Ⅱ (phenyl moiety) and Ⅲ (p-fluorophenylamine moiety). In the molecule, intermolecular hydrogen bonds between N(6)-H(6)…O(1)and C( 15)-H( 15)…O( 1 ) are observed.     

7,7-二甲基-2-对溴苯基-4-苯基-5-氧代-1,4,5,6,7,8-六氢化-6H-喹啉的合成及晶体结构

标题化合物C23H22BrNO是由1-(4-溴苯基)-3-苯基-2-丙烯-1-酮与5,5-二甲基-1, 3-环己二酮在N, N-二甲基甲酰胺(DMF)中在NH4OAc催化下反应而得。结构通过单晶X-射线衍射分析确定,其晶体属于单斜晶系,空间群C2/C, a = 19.678(4),b = 13.571(2),c = 17.311(3) 牛琤 = 118.74(1),Mr = 408.33, V = 4055(1) ?,Dc = 1.338 g/cm3, Z = 8, m (MoKa) = 2.038 mm-1, F(000) = 1680, R = 0.0539,wR = 0.1369。X-衍射分析表明,六元环C(10)C(13)C(16)C(17)采用半椅式构象:原子C(10),C(11),C(12),C(16)和C(17)在同一个平面内,而原子C(13)远离平面为0.3282 牛闷矫嬗?个苯环的夹角分别为41.09, 81.97,2个苯环的夹角为75.87。另外在晶体结构中,存在1个分子间氢键。     

One-pot Synthesis and Crystal Structure of （1S,2R,3S,4R,5S）-1-Phenyl-2,4-dibenzoyl-3,5-difurylhexanol

(1S,2R,3S,4R,5S)-1-Phenyl-2,4-dibenzoyl-3,5-difurylhexanol 1 was synthesized by one-pot reaction of hypnone and furfurol in alkali H2O/EtOH solution and structurally defined to contain a chair-formed aliphatic carbocycle, on which the bulky substituents occupy the equatorial positions.     

Synthesis and Crystal Structure of (2S,2'S,4'R)-2-(1-Hydroxy-1-ethylpropyl)-1-[(1'-p-tosyl-4'-hydroxypyrrolidin-2'-yl)methyl]pyrrolidine

1 INTRODUCTION In recent years, chiral β-amino alcohols have attracted much attention due to their special bio- logical functions and catalytic activities. Chiral β- amino alcohol moieties are usually found not only in natural products (e.g., cinchona alkaloids, ephe- drine, toxal, etc.) with special biological activities[1, 2], but also critical structural segments of some syn- thesized biologically active compounds, such as adrenergic agonists or antagolist[3, 4] and inhibitors for HI…